Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age.

Adv Ther · 2017 · PMC5331094 · PMID 28070861

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Clinical Efficacy in CD An overall trend favoring vedolizumab treatment was observed in the induction and maintenance phases of the GEMINI 2 study.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.